Excellent research results for CAR-T Cell therapy against Hodgkin lymphoma
CAR-T cell therapy, which attacks cancer cells using a person’s reprogrammed immune cells, has been…
Browsing: Haematology
Breakthrough with cancer vaccine
Scientists are ready to trial a new cancer vaccine in humans following the successful outcome…
Mapping the immune landscape of haematological cancers may help to enhance therapies
Activating the immune system of the body is a promising form of treatment for cancer.…
Blood cancer find raises new treatment hopes
New QIMR Berghofer research has identified how an early genetic change in blood and bone…
EHA 2020: Gut microbiome disturbance by antibiotic treatment early in life is sufficient to induce leukaemia in predisposed mice
Genetic predisposition to childhood leukaemia is frequent (>1-5%), but less than 1% of genetic carriers…
EHA 2020: A new treatment paradigm in relapsed refractory Hodgkin lymphoma
Patients with relapsed/refractory classical Hodgkin lymphoma (R/R cHL) have few treatment options when they are…
EHA 2020: A paradigm shift for the treatment of newly diagnosed older acute myeloid leukaemia patients
Acute myeloid leukaemia (AML) is primarily a disease of older adults. Standard commonly utilised lower-intensity…
EHA 2020: PET-guided therapy allows omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma
For decades, combined modality treatment (CMT) comprising of four cycles of chemotherapy and radiotherapy has…
EHA 2020: Combined irradiation and chemotherapy better prepares children for stem cell transplantation than chemotherapy alone
Treatment of childhood cancer is a success story, particularly for acute lymphoblastic leukaemia (ALL). More…
ASCO 2020: Combination therapy well-tolerated and highly effective for patients with IDH1-mutated AML
A combination therapy of ivosenidib (IVO) plus venetoclax (VEN) with or without azacitidine (AZA) was…